[pumper_stumper]

This month's Koos video conference just ended. It was horrible, even using RGBP standards. It was a 15 minute presentation, but by the two minute mark he was already out of new things to say, and started rehashing the same crap as the last few calls.

Highlights (comedic):

1) Actually acknowledged he printed himself shares to pay off debt, but of course did not address that he gave himself $500k in shares to pay off $50k owed to him. And had the nerve to say the purpose was to help clean up the balance sheet. This just in, he removed $50k of debt on a balance sheet which has $5.9 million in liabilities. In other words, he diluted the company by almost 50% to pay down less than 1% of the liabilities on the balance sheet! Classic Koos there!

2) Now that the audit was completed and as of late May they are fully SEC reporting, there are no obstacles for the offering to proceed. But unfortunately, one of the questions from shareholders was how much has been raised. The answer is $0, of course. Yet, still claiming there is "interest" from investors. How long can he string along his foolish shareholders with that line yet receive no funding? lol

3) Was also asked about if they applied for grants so of course had to answer no.

What really will be fun is that easily the next few conference calls will be pretty much just like this. It is possible he will eventually find a fool and get a small amount of funding. If he does, he'll be able to string this out another few months.... and fund his vacation/boat!

Meanwhile, there were zero claims that there is any activity is currently going on in the company... why not? Because there is nothing going on, and he isn't even going to try to convince anyone otherwise. They are just sitting around waiting for funding! This my friends, is comedy!

[pumper_stumper]

50% new dilution! Take a bow Koos!

While shareholders suffer, Koos just paid himself about $550K worth of RGBP shares to pay off $50K owed to him! This takes RGBP from 21 million to 31 million shares outstanding! If his shareholders were knowledgeable about basic finance, they'd know that 50% of their equity in this company is gone, in a flash! Of course, he knows his shareholder base, and knows this won't be understood!

His shareholders won't have a problem with this! Speak up if i am wrong on that.

Now, IF there was anyone really interested in purchasing the stock offering to finance testing, he just made the ownership 50% less attractive!

On June 10, 2025 Regen Biopharma, Inc.(“Company”} issued 10,000,000 common shares (“Shares”) to David R. Koos, the Company’s Chief Executive Officer. The Shares were issued in settlement of $50,000 salary accrued but unpaid earned by David Koos for services rendered pursuant to that employment agreement entered into by and between the Company and David Koos on February 10, 2015 and to which David Koos and the Company were bound between February 11, 2025 and January 22, 2020.

[SmellMyFinger]

It's about time!

[pumper_stumper]

All of this was required due to CEO Koos' incompetence, period! Anyone that claims otherwise simply doesn't understand the facts. His incompetence in neglecting 10 year old SEC filings caused the need to be SEC compliant again, as the SEC put the new dilutive offering on hold until this was done. Like in all scams, these events will be spun as progress and as an accomplishment.

Koos himself said on numerous occasions how not being SEC reporting was the way to go...... until the SEC required him to do so.

[Bigfootbud]

$RGBP $RGBPP Regen has filed all delinquent financial reports with the SEC and is now fully reporting and current with the SEC. Form 15 has been withdrawn at the SEC's request.

$RGBP $RGBPP
Regen has filed all delinquent financial reports with the SEC and is now fully reporting and current with the SEC. Form 15 has been withdrawn at the SEC's request.

We anticipate OTC markets should reflect these changes shortly.

— Regen BioPharma Inc. (@TheRegenBio) May 29, 2025

We anticipate OTC markets should reflect these changes shortly.

[Musical Shares]

The natives

🤣🤣🤣🤣

That is all.

[pumper_stumper]

The natives are getting restless! I loved reading the responses to Koos' post on X about the day's video conference. There were no supportive responses! These were the only responses:

This was one of the worst presentations to date. Can you and Harry at least create some professional video conference backgrounds instead of your messy bedroom? You need a new face for Regen to clearly present info that is concise and with good energy instead of a 12 min ramble.

really!!!!!!!!!!!!!????????????? a company is meant to do business not be in conferences every single week!!

More dilution?

Can yall buy my shares back? they are -99.89% since Koos RS a perfect setup

Why are you all not in prison?

So when will my shares I bought back in 2020 come back up 99.2% so I can break even? How about some answers dirt bag Koos? How many more people you want to screw with your BS dilution to enrich yourself? You've screwed every shareholder for your personal benefit!

Ohh heck no. I am afraid to ask a question to Koos and backfires with more dilution or another R/S sm

Is it easy to sleep at night knowing how many investors you screwed?

[Musical Shares]

Thanks for making me chuckle throughout that whole post. 🤣 Entertaining indeed.

[pumper_stumper]

It was only 10 minutes long. He actually admitted that the 10Q is still not done yet (overdue), will be in 1-2 weeks. As such they are still not fully SEC Compliant and the offering still cannot take place. So company-wise, nothing took place in the month other than paying the auditor.

Another fun thing is because they have no cash, he himself had to fund the audit. Of course he fails to mention that if there are any shares sold he is going to get his money back, and then some, of course.

A classic moment is when he addressed a question from a shareholder that was sent to him before the conference, as to why did they suddenly abandoned (my word) Car-T and went back to Hemaxellerate. Of course, this was a business question, and he is the only exec and the freakin CEO. So what does he do? He passed the question on to his scientific advisor who isn't even an employee. He acted like a deer in the headlights, but did actually say it was a business decision, not a scientific one, which for anyone with intelligence listening would be cringe worthy moment. Embarrassing! Classic Koos!

The last classic moment was when the tried to use the Chicken and the Egg analogy.... but couldn't remember how it went and dropped it, saying he was getting old. Sure, too old to remember a simple well known analogy but not too old to single handedly run a "bio tech drug company"? Entertaining for sure!

The replay should be up on youtube tonight or tomorrow

The advantage of having a 10 minute limit is that somehow they ran out of time and could not take any questions... darn!

Come to think of it after re-reading the above, for a 10 minute call it was very entertaining!

[Musical Shares]

So, how did it go? Did you listen in? Get a couple of chuckles out of it?

[pumper_stumper]

For those entertained by Koos and evasive monthly conference calls, there is a 15 minute one today at 3:10 Eastern time. He is going to tell us about the completion of the audit that the SEC demanded before allowing him to do more financing, which was already announced a week ago. There will be very little other content, other than to ramble how it's the SEC's fault that the financing was help up, rather than admitting that it was his own incompetence in not closing the 10 year old SEC Form 8 that he left open. Should be fun yet boring as hell, as always. But, being 15 minutes, it should curtail his meaningless chattering.

He still hasn't posted the first quarter 10Q, and has yet to file for an extension, so RGBP is in Pink Limited Information status on OTCMarkets. I can't imagine him nor his shareholders caring one bit about that!

In January 2023, this was $4.00!
Last trade was at 0.041 which for all intents and purposes, is an all time low!

More shareholders paying the price, through losses, for not doing proper due diligence. Those that invest in scams are helping them, and will be punished this way!

[pumper_stumper]

1st Quarter 2025 financials not filed on time, and no extension request filed.

Does Koos even care anymore? Isn't really trying much!

[Musical Shares]

So was it planned, or is he THAT incompetent? One of those has to be true. That's part of what makes pinks so fun to watch!

Spot on. 🤣 Will never know but the mystery continues!

[pumper_stumper]

You almost have to wonder, is he smart enough to have planned this so that he could get a 6-9 month free pass for having zero progress? Of course, if this were a real company, an audit wouldn't stand in the way of drug development. But this is a one thread company, anything can be used as an excuse to hold up all progress on everything.

So was it planned, or is he THAT incompetent? One of those has to be true. That's part of what makes pinks so fun to watch!

[Musical Shares]

What does this mean? MANY MANY months of blaming the auditors for delays, and throwing up his hands when asked for status and end date. "that's up to the auditors and I'm having a hard time getting a date from them"

Ah yes, the old "we can't go forward until we correct this issue and it's not our faults but these peoples fault" routine. 🤣

Always a crowd pleaser.

He gets an "extension of time" so shareholders forget about it AND a "we are actively working on this business" combo here.

Stupendous. 👏

He was asked how much was raised before the SEC stopped them. His reply? "A bunch of money".

🤣

That's a good measurement. Completely neutral and subjective. 😏

He really out did himself on this one!

[pumper_stumper]

Summary of today's conference call!

BIG ONE! The SEC shut down RGBP's new offering due to an existing offering from "5,6, 8 years ago" (his exact words) still being open! (aren't you impressed with how much he knows about his own company? 5,6 or 8?)

You want to talk about CEO incompetence? This is an all time great! Not even being aware that his prior offering from YEARS ago was still open! It's a one person company, he has no one else to blame!

So, NOW, they have to do a 180, rescind the Form 15 filing that made them not SEC compliant, and NOW they have to get audited first, and close the old offering, then restart the new offering before any financing can begin! Just realize that he did already try to get reaudited, for MONTHS, but then stopped in the middle of it, last year. Of course, common sense would tell you the audit was stopped because the audit found issues!

Well now the SEC is forcing him to restart the audit before any offering can be done!

What does this mean? MANY MANY months of blaming the auditors for delays, and throwing up his hands when asked for status and end date. "that's up to the auditors and I'm having a hard time getting a date from them"

He was asked how much was raised before the SEC stopped them. His reply? "A bunch of money". How's that for transparency? The funds had to be returned.

So, more evidence of incompetence and doing anything but being very transparent!

Now he gets months more of doing nothing, and gets to blame the delay to riches on someone else! This is a scammer CEO's dream situation!!!!

[pumper_stumper]

Well we get a 30 minute song and dance show today from Koos (video conference call). What can we expect? Avoidance of discussing actual funding received, more meaningless talk about "setting parameters and milestones of the early parts of the test" (same thing said in prior one), and lots of "we're excited"! Then we'll get to hear Mr Science ramble of about how some drugs theoretically act biologically, but ZERO on any recent actual published testing results, because there are none. Will be interesting to see how he fills up a half hour, since NOTHING will be done in testing unless they get funding.

[Musical Shares]

I'll roll the dice and say that never happened. The dude is still working on getting funding for this IND from 10 years ago. Clearly, he failed that dissertation. 😆

I mean, does the 10 minute video conference calls not give you a glimpse as to what he would be like "telemarketing?" 🤣

On a side note, here is a testimonial from AIU on their website from Koos:

https://www.aiu.edu/testimonials/david-r-koos-venture-bridge-managing-director/

[pumper_stumper]

Well think about what we might be missing. His thesis showed how biotechs like Amgen and Regeneron were actually funded by telemarketing, and ended up where they are today! Imagine all those late night cold calls to Grandmothers, who sent in their $50 money orders and seeded these companies that became mainstays in the drug world!

I wouldn't be surprised if Koos himself states that he was involved in this, on the ground floor, working the lines.

[Musical Shares]

Who needs to read it.... we are living it. 🤣

[pumper_stumper]

Thanks, since he went to an uncredited online "University" (the pink sheet equivalent of education), likely they don't participate in posting such great works as Mr Koos online. It likely would be an embarrassment anyway. I searched for both thesis and dissertation.

PhD theses are generally publicly available and searchable—especially in the U.S., U.K., Canada, and many other countries with open academic publishing norms. Here’s how it typically works:

🔍 Where PhD theses are usually found:
University Repositories
Most universities require PhD candidates to deposit their dissertation in a digital repository (e.g., Harvard DASH, MIT DSpace, etc.), which are indexed and searchable online.

ProQuest Dissertations & Theses
In the U.S., ProQuest is a massive database of theses and dissertations. Many American universities submit all PhD theses here. Access may require a subscription, but basic search is open.

Google Scholar / WorldCat / Open Access Repositories
Some theses also appear here, especially if the author has uploaded them to academic sharing platforms like Academia.edu or ResearchGate.



I was unable to locate a publicly available PhD thesis titled "Examining the Efficacy of Telemarketing Fundraisers as a Venture Capital Alternative in the Biotechnology Industry: A Case Study of Cell Bio-Systems, Inc" authored by David Koos in major academic databases or repositories. This specific work does not appear in platforms such as arXiv or Taylor & Francis, and there are no publicly available records indicating its publication.

?I was unable to locate a published paper titled "Examining the Efficacy of Telemarketing Fundraisers as a Venture Capital Alternative in the Biotechnology Industry: A Case Study of Cell Bio-Systems, Inc" authored by David Koos in major academic databases or repositories.

If this thesis exists, it might be an internal report, a conference presentation, or a document with limited distribution. To pursue further information, you might consider:

Contacting Cell Bio-Systems, Inc.: They may have archives or records of internal studies or reports.?

Reaching out to David Koos directly: If he is affiliated with an institution or organization, they might provide contact information or access to his publications.?

Exploring business registries or press releases: Sometimes, companies release summaries or findings of studies in press releases or business filings.

[Musical Shares]

I only read the dissertation title a long time ago. It’s located in some of the SEC reports filed.

Never found the actual paper.

Here is the actual title:

Examining the Efficacy of Telemarketing Fundraisers as a Venture Capital Alternative in the Biotechnology Industry: A Case Study of Cell Bio-Systems, Inc

[pumper_stumper]

Investing in pinks sheets largely is about making unfounded jump the gun readings into company statements that are so extreme that they amount to pure fiction.

This idea of a buyout being "indicated" by that statement is one of my top 10 ever!

I've said 100 times, there is a price to pay for using imagination and wishful thinking instead of facts when investing... the price is losses, which are proper and just, just like the +95% decline here.

[pumper_stumper]

You know, I've been looking for anything published by him for his non accredited college degrees, but have yet to find this. Do you have a link?

I still chuckle when I read the dissertation title to his "PhD" paper on "telemarketing fundraisers on venture capital."

[Musical Shares]

If you type into a search engine "David Koos" the first "suggestion" comes up with "David Koos fraud." 🤣

What a masterpiece.

I still chuckle when I read the dissertation title to his "PhD" paper on "telemarketing fundraisers on venture capital."

That fits perfect for the garbage "PR's" he uses for his shareholders. Talk about funding capital through telemarketing in the OTC. 🙄🤣

[Fdc4]

That doesnt apply in WallStreet honey AND much less at OTCM… Thats a very naive statement in this field; wrong place to bring that up… Chuckles

[Fdc4]

Did you really believe on his buyout response? Chuckles… Heck no…. Koos will pass this sucking blood business when he is done, to his heir. Endless dilution, we are the cow

[Fdc4]

Mate!!! You did reply to me with that nonsense back in 2022… Could you share any advancement on your buyout speculation response?

Wait dont bother, I can help: NONE

Didnt I tell you what he was trying to do?

I told you so

[Musical Shares]

I learned a long time ago that being a pessimistic person is way better on the mind, body and soul. My philosophy is, if you are already negative about everything then it can't get worse. If it becomes positive, then you just won.

Stupid simple. 🤣

There are three (3) principles I live by:

1. I watch lazy people to find the easiest and most efficient way to do things.
2. I listen to negative people before starting something to find out all the ways it could go badly.
3. And I learn from stupid people who teach me what not to do.

Yes, anyone that took a look a a 5 year history here (something that no shareholder here has ever done), you can see he just jumps from working on drug to drug, each time it is because the other one suddenly has a better business case.

This is the same thing as the "biotech" trick called "screening platform acquisition" in the OTC. A ticker will "acquire" a "screening platform," call themselves a "biotech" company and never actually produce anything other than "data" and then write about it. The idea is a biotech never needs to make revenues and only has to produce fluff PR's to keep shareholders motivated.

It's the same thing Koos is doing with bouncing back and fourth here. It's simple, effective and keeps the "company" alive.

The video conference calls are always hilarious. 10 minutes of him sitting in a chair in a room painted with white walls only where he keeps saying the same things as last year. 🤣

It still cracks me up that he writes in his annual reports that he rents a space from his own "realty company" and calls it his home/office/lab. I get the home/office but scientific research lab? 🤣

What are you working with a 1956 science kit?

[pumper_stumper]

Any updates on the buyout that was "indicated"?

Buyout Indicated, indirectly, in a previous 8k

Another example of the unlimited imagination of pink sheet investors! They can read positives into anything and everything!

There is a price for doing that though... losses, when reality hits.

[pumper_stumper]

You are one of the rare ones that see this for what it is and yes, the comedy factor is reason alone to follow.

Koos called off the last paid video conference call, which was scheduled to be only 10 minutes long, hours before it was to start, due to "bronchitis", which had me in stitches. The idea a CEO couldn't make it through a 10 minute call for that is just ridiculous.

Yes, anyone that took a look a a 5 year history here (something that no shareholder here has ever done), you can see he just jumps from working on drug to drug, each time it is because the other one suddenly has a better business case. I haven't posted all my recent findings, but he did try to run HemaXellerate through some central american testing, about 9 years ago, and like usual, for a while posted all the "great progress" (with zero data or proof) until either the results showed it was going nowhere, or he ran out of $. Now, years later, he's back with it, and if he gets some funding, best case, will run the same preliminary lab set up and simple early tests as he did 9 years ago, and pocket the rest of the offering $.

Just like you, I have a history of pink sheet CEOs changing their approach due to my posts. Good old Roxanna Weber of Emax used to say "soon" all the time, in answer to when things would be completed, a totally meaningless word. Well for months me and a few others would just post silly things about the answer being "soon", and ridiculing her. It became a running joke. Well after months of this, she instead started saying "in the very near term", which was a great compliment to me, and just as funny and pointless.

[Musical Shares]

Thanks for the explanation.

My favorite part was:

Midstream in the "great progress" testing one of his drugs, he stopped dead on that testing, and went back to HemaXellerate, which had an IND like a decade ago, and he claims he is going to raise money to do a phase 1 test on it. The best part is that he did this ONLY after I submitted a question on his call, months ago, to embarrass him as to why he did nothing with this drug, 10 years after getting an IND! The next month he announced the shift back to HemaXellerate! (ping pong) So basically I am calling the shots here!

Nice work!

I had something similar on another ticker where I wrote these posts and the next day the "CEO" would magically write a "PR" on the exact things I pointed out! He even went as far as to copy and paste one post telling him how to run his business!

Comedy gold. Needless to say he gave up when I just kept pointing things out and "sold" the ticker. 🤣

This guy is definitely playing ping pong. In what world does someone create an IND, abandon it and then state he is bringing it back? If something was actually good then many "big pharma's" and even medium size would be interested in helping to fund it.

It seems he is still doing this "I'm working on funding" bit.

This is like real life Seinfeld. Only better.

[pumper_stumper]

Yes, I figured I would see if I could lure you back here! I miss seeing your posts here, and yes, I'm back.

Although post wise, seems like the cheerleaders for this scam are either in hiding or licking their wounds, the Koos scam still continues!

Well you might have missed that months after the reverse he paid a "dividend" which in effect undid part of the reverse. These additional shares were like throwing gasoline on a fire, and sent it lower. He knew that pink sheet investors see the word "dividend" and jump to the conclusion this means the company is growing. Instead, they got Koos'ed again!

Midstream in the "great progress" testing one of his drugs, he stopped dead on that testing, and went back to HemaXellerate, which had an IND like a decade ago, and he claims he is going to raise money to do a phase 1 test on it. The best part is that he did this ONLY after I submitted a question on his call, months ago, to embarrass him as to why he did nothing with this drug, 10 years after getting an IND! The next month he announced the shift back to HemaXellerate! (ping pong) So basically I am calling the shots here!

There is another video call next week where he will dance around this again, wanting to give people the impression his is making progress raising more money, yet still will not be going forward with any testing. Just lots of talk of "being excited". The over under on that phrase is about 5 per call!

[Musical Shares]

Are my eyes deceiving me? Pumper Stumper? It's been a while......

You brought up a 2 year old post.... 🤣

I've been out of this thing for a long time.

Good to see you want a laugh still out of this "biotech."

I see the price is at 5 cents. I thought the stock was suppose to go up after that massive reverse split? What happened? 😆

[pumper_stumper]

He literally says he was to aggressive with the R/S then proceeds to say "get over it."

That's just great. I want to see if I can find that one!

[SmellMyFinger]

Waiting for $0.01s to average down.

[pumper_stumper]

Some drama here. Does Koos sign up for the next conference April 16/17? Or does his "illness" continue! Stay tuned!

[pumper_stumper]

I had to re-read that. I thought you meant the CEO is heavier than us (which he most certainly is). Pink sheet CEO's always eat well on the shareholders dimes. Take a look at how many are very overweight.

[Fdc4]

That guy is healthier than us, he is not going nowhere and if he is, someone else will take over his Con-space. Let dilution and blood sucking continues.

Rgbp-Rgbpp : 🚨S.C.A.M ALERT🚨

[SidVicious]

Remember folks, a few of us exposed this scam 10+ years ago yet the pump and dumpers on here fooled a lot of you suckers into thinking this was a sure thing. How does it feel now to know that not only did you get scammed by the pump n dumpers on here, like 29IQinvestor who should be in jail for being a white collar message board criminal, but that you failed to heed our warnings? Now you have a huge capital gains loss. Koos is a white collar criminal using the OTC to subsidize his life style of italian sports cars and small boat yachting. I'm still waiting for that fat phuck to tell us what exactly his brother did for all that money he paid him? A good accountant will probably find that the payment wasn't for any work to be done but was paid to pay his brother back for a personal loan, imo.

[pumper_stumper]

Who said: " The market teaches expensive lessons, and has no sympathy. For those who continue to ignore facts, there are more declines coming, I PROMISE!"

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=169149951

Since I was hear last, RGBP has (Split adjusted) fallen from $2.92, to $0.05 So down only 98% In just 15 months! And this after 90% declines from prior years! Sick! And Fun!

Nothing has changed except SOME of the long time shareholders with 99+% losses are starting to see the light! Is that all it takes to figure it out!

Once again, the market teaches expensive lessons. If you continue to invests in scams, the market will teach you expensive lessons! It still holds!

It's so joyful to see when markets work!

[pumper_stumper]

DD challenge: Koos chose ClinDatrix to do the Phase 1 trial for their 9 year mothballed "miracle drug" that he suddenly decided to resurrect.

Any good quality proper due diligence on ClinDatrix would show why these 2 pathetic companies are perfect for each other. Remember, this is the company they hand picked to do the work to move this through this phase's trial. My challenge is to post what you found on them. It should be easy, but you do need to do more than just google and rehash the words. You need to judge their past history What did you find? Not doing a proper job in this will result in... guess what... more losses here!

[pumper_stumper]

It was filed because Koos's auditor was a slimeball (similar types attract each other), and was banned from auditing by the SEC. The SEC notes show that basically this auditor would hardly look into things. In other words the perfect auditor for a pink sheet scam! The SEC required all companies that this auditor audited, to hire a REAL auditor and get re-audited. You know Koos won't stand and pay for a real audit!

As such they are no longer an audited company. Koos initially did try to hire a new auditor, but this new one was legitimate, so no way RGBP was going to pass without a lot of work/rework. So Koos stopped the audit and it's no longer even being pursued! (this is the pinks, who cares about being audited... he knows his audience! )

This means that they can no longer be an SEC reporting company, so he had no choice but to file a SEC 15 to cut ties with the SEC and get back to what all "quality" companies do, being alternative reporting via OTC Markets.

[pumper_stumper]

Today's presentation is cancelled! Time to better expose this scam! Today $RGBP had a 10 minute video presentation scheduled. Koos does these from his home office. You know, the one shareholders pay $5,000 a month rent for. Anyway, he posted on X today that he won't be participating due to "bronchitis".

Anyone who believes that likely also believe that RGBP was a good buy at $5.

[Bananaman73]

https://www.facebook.com/share/r/15rNwaKvYo/?mibextid=eBqqwY

[SmellMyFinger]

Reverse/splits in general are a waste of time and simply function to dilute the stock and decrease shareholder value.

[TAKURI]

pps 0.0765 / 1500(rs) = 0,000051 real pps

[wildwolf1]

That RS really did this stock in, and took a lot of money from Us believers in this thing. What is the latest based on the below filing?

[bigtalan]

It took awhile , but it is where it was almost when the R/S took place . Koos and his scams
This phrase refers to a legal document, specifically "Form 15" filed with the Securities and Exchange Commission (SEC), which essentially signifies a company's certification that it is terminating its registration of a class of securities under Section 12(g) of the Securities Exchange Act of 1934, meaning they no longer need to file periodic reports because they have become a private company, or that they are suspending their duty to file reports under Sections 13 and 15(d) of the same act; effectively removing their public reporting obligations.
Key points about this phrase:
Form 15: This is the official SEC form used to make this notification.
Section 12(g): This section of the Securities Exchange Act outlines the requirements for a company to register its securities with the SEC and become subject to periodic reporting.
Sections 13 and 15(d): These sections dictate the specific reporting requirements that a public company must follow.
When a company might file this form:
When the number of shareholders of a publicly traded class of securities falls below a certain threshold, allowing them to "go private".
If a company is undergoing a merger or acquisition that results in a significant reduction in public shareholders.

[A51Rob]

Is Regen Biopharma going private?